DNA ligase is the enzyme that seals breaks in the DNA backbone. Wherever a gap exists between two DNA segments, ligase joins them by forming a chemical bond called a phosphodiester bond, creating one continuous strand. This makes it essential for DNA replication, DNA repair, and laboratory techniques like gene cloning.
How DNA Ligase Seals a Break
The ligation reaction happens in three steps. First, the enzyme picks up a small energy molecule (AMP) from a cofactor and attaches it to itself, creating a charged-up intermediate. Second, it transfers that AMP onto the broken end of the DNA at the 5′ phosphate side of the nick. Third, the 3′ hydroxyl group on the other side of the nick attacks that activated phosphate, forming a new phosphodiester bond and releasing the AMP. The result is a sealed, continuous sugar-phosphate backbone.
The energy source for this reaction differs by organism. Eukaryotes (humans, animals, plants) use ATP as the cofactor. Bacteria use a different molecule called NAD+. This distinction matters: because bacterial ligases rely on a cofactor that human ligases don’t, the bacterial version is a potential target for antibiotics.
Joining Okazaki Fragments During Replication
DNA ligase plays its most frequent role during DNA replication. Because DNA polymerases can only build new DNA in one direction (5′ to 3′), one of the two strands has to be copied in short, discontinuous pieces called Okazaki fragments. Each fragment is roughly 100 to 200 nucleotides long in eukaryotes. DNA ligase seals the nicks between these adjacent fragments to produce a single intact strand.
In human cells, DNA ligase I handles this job. Its catalytic region wraps around the DNA at each nick, forming a ring-like structure that works in concert with a sliding clamp protein called PCNA. Together they move efficiently along the replication fork, sealing fragment after fragment. When ligase I is missing or defective, the downstream Okazaki fragment gets displaced and degraded instead of joined, leading to incomplete replication and genomic instability.
Repairing Damaged DNA
Your cells sustain thousands of DNA lesions every day from normal metabolism, UV light, and environmental chemicals. Several repair pathways fix this damage, and nearly all of them end with the same final step: DNA ligase sealing the last remaining nick after the damaged section has been cut out and replaced.
In base excision repair, the pathway that fixes small, single-base errors like oxidized or alkylated bases, the process works in five core steps: a damaged base is removed, the backbone is cut, the gap ends are cleaned up, a polymerase fills in the correct nucleotide, and then a ligase seals the nick. DNA ligase I appears to be the primary enzyme for this final step in the nucleus, while DNA ligase III handles the same job inside mitochondria.
For double-strand breaks, where both strands of the helix are severed, the stakes are much higher. The main repair pathway in human cells is called non-homologous end joining (NHEJ). Here, DNA ligase IV does the critical work. It operates as part of a multi-protein complex: ligase IV binds to a scaffold protein (XRCC4) and an additional factor (XLF), and this assembly is recruited to the broken chromosome ends. Ligase IV then re-joins them. This is the final, essential step of the pathway.
Three Human DNA Ligases, Three Jobs
Humans have three genes encoding DNA ligases, and each has a distinct specialty:
- DNA ligase I is the workhorse of replication and excision repair. It seals nicks between Okazaki fragments and closes the final gap after base excision repair and nucleotide excision repair in the nucleus.
- DNA ligase III partners with a protein called XRCC1 for single-strand break repair and is the essential ligase inside mitochondria. For years it was thought to be the main ligase for base excision repair in the nucleus, but more recent evidence shows ligase I fills that role.
- DNA ligase IV is dedicated to double-strand break repair through non-homologous end joining. It also plays a role in a process called V(D)J recombination, which immune cells use to shuffle gene segments and generate the diversity of antibodies and T-cell receptors.
All three catalyze the same basic chemistry, forming a phosphodiester bond, but they differ in which protein partners they bind and which DNA structures they recognize. Ligase I, for example, has no ability to join two separate DNA molecules end-to-end. It only seals internal nicks. Ligase IV, working with its partners, can bring two free DNA ends together.
What Happens When DNA Ligase Is Defective
Because ligase seals breaks in every major DNA pathway, losing it has serious consequences. LIG4 syndrome is a rare inherited disorder caused by mutations in the gene for DNA ligase IV. Because the enzyme can’t properly repair double-strand breaks, affected individuals develop microcephaly (an abnormally small head), growth and developmental delays, unusual facial features, skin sensitivity to light, and a severely weakened immune system. Symptoms appear in newborns or infants and include pancytopenia, a dangerous drop in all blood cell types. Some patients develop acute leukemia. The condition is autosomal recessive, meaning a child must inherit a defective copy of the gene from both parents.
Deficiency in DNA ligase I similarly causes problems. Cells from a ligase I-deficient patient show defective Okazaki fragment joining and heightened sensitivity to DNA-damaging agents, particularly chemicals that alkylate DNA.
Uses in Biotechnology
DNA ligase is one of the foundational tools of molecular biology. T4 DNA ligase, originally isolated from a virus that infects bacteria, has been used for over fifty years in laboratories worldwide. Its primary job in the lab is the same as in a cell: joining DNA fragments. When scientists cut a gene of interest and a circular DNA vector with the same restriction enzyme, T4 DNA ligase seals the gene into the vector, creating recombinant DNA. This is the basis of molecular cloning.
Beyond cloning, T4 DNA ligase is used in library construction (creating large collections of DNA fragments for screening), high-throughput DNA sequencing, and even the detection of small RNA molecules. Its versatility comes from its ability to join both nicks in intact DNA and, under the right conditions, blunt or sticky ends of separate DNA fragments.
DNA Ligase as a Cancer Target
Because cancer cells rely heavily on DNA repair to survive the genomic chaos of rapid division, researchers have explored whether blocking specific ligases could make tumors more vulnerable. Recent work on prostate cancer found that high expression of DNA ligase IV correlates with poor prognosis. In animal models, inhibiting ligase IV caused double-strand breaks to accumulate in cancer cells, triggering cellular senescence (a state where cells stop dividing). It also reduced the population of cancer stem cells. When ligase IV inhibition was combined with an immune checkpoint drug (a PD-1 antibody), tumors shrank significantly, from an average of 245 mm³ to 179 mm³, driven by an influx of immune cells that could now recognize and attack the damaged cancer cells.